老年骨质疏松常用治疗药物的研究现状及展望  

The present and progress of common drug therapy in treating senile osteoporosis

作　　者：李沫[1] 王海旸 王丽娟[1] 肖建林 高忠礼[2] 蔡寒青[1] Li Mo;Wang Haiwei;Wang Lijuan;Xiao Jianlin;Gao Zhongli;Cai Hanqing(Department of Endocrinology,the Second Hospital of Jilin University,Changchun 130041,China;Department of Orthopaedics,the Second Hospital of Jilin University,Changchun 130041,China)

机构地区：[1]吉林大学第二医院内分泌科,长春130041 [2]吉林大学第二医院骨科,长春130041

出　　处：《中华老年骨科与康复电子杂志》2019年第6期365-369,共5页Chinese Journal of Geriatric Orthopaedics and Rehabilitation(Electronic Edition)

摘　　要：骨质疏松是常见的老年疾病之一,目前尚无有效的根治方法。药物治疗作为骨质疏松患者早期预防用药在改善临床症状,防止骨折发生具有重要的作用。随着骨质疏松治疗药物的种类逐年增多,对药物的疗效及副作用方面的理解也越来越多。本文对骨质疏松的实验室及临床相关研究进行阐述,就骨质疏松药物治疗方面的有效性及安全性进行综述,以此对临床治疗提供参考。Osteoporosis is a very common disease among elderly people but still no effective therapy to cure.Drug therapy as the prevent treatment in osteoporosis has been proved valuable in releasing the clinical symptom and prevent the progress of fracture.With the increasing variety of osteoporosis drugs,the comprehension of the effect and side effect of drugs are growing.The laboratory and clinical studies of osteoporosis were reviewed,and the efficacy and safety of drug were summarized in this article,hopefully it can provide theoretical basis for clinical treatment of osteoporosis.

关 键 词：骨质疏松症 药物治疗 双膦酸盐 甲状旁腺素 

分 类 号：R68[医药卫生—骨科学]